- Home
- WAT vs SYF Comparison
WAT vs SYF Comparison
Compare WAT & SYF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WAT
- SYF
- Stock Information
- Founded
- WAT 1958
- SYF 1932
- Country
- WAT United States
- SYF United States
- Employees
- WAT N/A
- SYF N/A
- Industry
- WAT Biotechnology: Laboratory Analytical Instruments
- SYF Finance: Consumer Services
- Sector
- WAT Industrials
- SYF Finance
- Exchange
- WAT Nasdaq
- SYF Nasdaq
- Market Cap
- WAT 20.1B
- SYF 20.3B
- IPO Year
- WAT 1995
- SYF N/A
- Fundamental
- Price
- WAT $342.65
- SYF $62.34
- Analyst Decision
- WAT Buy
- SYF Buy
- Analyst Count
- WAT 15
- SYF 21
- Target Price
- WAT $387.60
- SYF $62.55
- AVG Volume (30 Days)
- WAT 424.4K
- SYF 3.1M
- Earning Date
- WAT 07-30-2025
- SYF 07-16-2025
- Dividend Yield
- WAT N/A
- SYF 1.92%
- EPS Growth
- WAT 8.23
- SYF 4.77
- EPS
- WAT 11.02
- SYF 7.27
- Revenue
- WAT $2,983,253,000.00
- SYF $8,705,000,000.00
- Revenue This Year
- WAT $6.07
- SYF $99.94
- Revenue Next Year
- WAT $6.44
- SYF $5.30
- P/E Ratio
- WAT $31.07
- SYF $8.60
- Revenue Growth
- WAT 2.57
- SYF 0.44
- 52 Week Low
- WAT $279.24
- SYF $40.55
- 52 Week High
- WAT $423.56
- SYF $70.93
- Technical
- Relative Strength Index (RSI)
- WAT 46.54
- SYF 62.47
- Support Level
- WAT $334.00
- SYF $60.01
- Resistance Level
- WAT $349.91
- SYF $61.65
- Average True Range (ATR)
- WAT 8.05
- SYF 1.44
- MACD
- WAT -1.13
- SYF 0.04
- Stochastic Oscillator
- WAT 38.09
- SYF 95.81
About WAT Waters Corporation
Water sells liquid chromatography, mass spectrometry, and thermal analysis tools. These analytical instruments provide essential information on various products, such as their molecular structures and physical properties, to help clients enhance the health and well-being of end users. As a percentage of sales in 2023, Waters generated 57% from biopharmaceutical customers, 31% from industrial clients, and 12% from academic/government institutions.
About SYF Synchrony Financial
Synchrony Financial, originally a spinoff of GE Capital's retail financing business, is the largest provider of private-label credit cards in the United States by both outstanding receivables and purchasing volume. Synchrony partners with other firms to market its credit products in their physical stores as well as on their websites and mobile applications. Synchrony operates through three segments: retail card (private-label and co-branded general-purpose credit cards), payment solutions (promotional financing for large ticket purchases), and CareCredit (financing for elective healthcare procedures).